Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • AUXILIUM PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 113.94 M 76.09 M 54.74 M 56.73 M 46.81 M
    Net Receivables 16.96 M 12.30 M 9.77 M 4.81 M 4.99 M
    Total Inventories 9.47 M 5.14 M 2.81 M 4.39 M 4.01 M
    Progress Payments & Others 0.00 0.00 0.00 216,000.00 478,000.00
    Prepaid Expenses
    Other Current Assets 2.47 M 3.13 M 2.19 M 2.36 M 2.19 M
    Current Assets Total 142.84 M 96.66 M 69.51 M 68.30 M 58.00 M
    Long Term Receivables 0.00 0.00 0.00 0.00 17,000.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 3.42 M 400,000.00 0.00 0.00 0.00
    Property, Plant & Equipment Net 16.55 M 7.90 M 4.73 M 3.69 M 2.55 M
    Property, Plant & Equipment Gross 22.24 M 11.61 M 7.21 M 5.26 M 3.68 M
    Accumulated Depreciation 5.69 M 3.71 M 2.48 M 1.57 M 1.13 M
    Other Assets 8.38 M 2.02 M 2.52 M 709,000.00 485,000.00
    Deferred Charges
    Tangible Other Assets 8.38 M 2.02 M 2.52 M 709,000.00 485,000.00
    Intangible Other Assets
    Total Assets 171.19 M 106.98 M 76.76 M 72.70 M 61.06 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 5,000.00 61,000.00 260,000.00 427,000.00
    Accrued Payroll 8.28 M 6.76 M 4.97 M 3.67 M 3.03 M
    Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 45.77 M 21.09 M 15.59 M 12.20 M 9.65 M
    Current Liabilities Total 55.50 M 31.80 M 22.69 M 21.24 M 15.97 M
    Long Term Debt 0.00 0.00 5,000.00 65,000.00 323,000.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 80.42 M 11.17 M 11.73 M 11.51 M 8.50 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 0.00 0.00 0.00 0.00 0.00
    Total Liabilities 135.92 M 42.96 M 34.43 M 32.82 M 24.80 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 35.27 M 64.02 M 42.33 M 39.87 M 36.26 M
    Common Stock 424,000.00 408,000.00 357,000.00 292,000.00 206,000.00
    Capital Surplus 307.66 M 288.12 M 225.58 M 177.43 M 135.86 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -1.28 M -29,000.00 104,000.00 -416,000.00 -565,000.00
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -270.46 M -224.17 M -183.46 M -137.52 M -99.26 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 5,000.00 2,000.00 0.00 21,000.00 -31,000.00
    Unrealized Gain (Loss) on Marketable Securities -135,000.00 83,000.00 0.00 0.00
    Treasury Stock 1.08 M 322,000.00 113,000.00 0.00 0.00
    Total Liabilities & Shareholders Equity 171.19 M 106.98 M 76.76 M 72.70 M 61.06 M
    Common Shares Outstanding 42.37 M 40.74 M 35.66 M 29.24 M 20.65 M